Crowley Elizabeth

CIK 00016818541 companyHAMPTON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001681854

Recent Transactions

30 trades

Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2025-06-05+85,000→ 85,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-06-14$10.38/sh+30,000→ 39,074 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2024-06-14−30,000→ 46,500 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-06-14$34.87/sh−30,000→ 9,074 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2024-06-13+85,000→ 85,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-06-07$10.38/sh+7,500→ 16,574 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2024-06-07−7,500→ 0 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2024-06-07−7,500→ 76,500 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-06-07$9.02/sh+7,500→ 24,074 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-06-07$35.06/sh−15,000→ 9,074 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-05-30$2.78/sh+34,445→ 39,171 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-05-30$9.02/sh+8,500→ 47,671 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2024-05-30−34,445→ 0 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-05-30$33.64/sh−38,597→ 9,074 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2024-05-30−8,500→ 7,500 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2023-06-15+80,000→ 80,000 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2022-06-16+77,000→ 77,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2021-12-08−4,000→ 16,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-12-08$9.02/sh+4,000→ 8,726 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-12-08$40.00/sh−4,000→ 4,726 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-11-01$2.78/sh+8,555→ 9,043 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-11-01$44.12/sh−2,528→ 6,515 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-11-01$43.11/sh−600→ 5,915 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-11-01$41.62/sh−1,189→ 4,726 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2021-11-01−8,555→ 34,445 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2021-06-17+58,000→ 58,000 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2020-06-18+84,000→ 84,000 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2019-06-19+43,000→ 43,000 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2018-06-13+300,000→ 300,000 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2017-06-15+82,000→ 82,000 total

Companies

Celldex Therapeutics, Inc.
SR. VP & CPDO
$CLDX

Recent Filings

Address

C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220

HAMPTON, NJ, 08827

View on SEC.gov